← FDA DRUG APPROVALS
FDA ANDA · ANDA212338
METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATE
Sponsor: MACLEODS PHARMS LTD
APPLICATION
ANDA212338
TYPE
ANDA
ROUTE
FILM COATED
DOSAGE FORM
TABLET, TABLET:FILM COATED
MARKETING STATUS
None (Tentative Approval)
Products
METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATENone (Tentative Approval)
METFORMIN HYDROCHLORIDE || SITAGLIPTIN 500MG · TABLET · FILM COATED
METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATENone (Tentative Approval)
METFORMIN HYDROCHLORIDE || SITAGLIPTIN 1000MG · TABLET · FILM COATED
METFORMIN HYDROCHLORIDE AND SITAGLIPTIN PHOSPHATENone (Tentative Approval)
METFORMIN HYDROCHLORIDE || SITAGLIPTIN 50MG · TABLET:FILM COATED
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.